16 Jul 2008 BioWa and Medarex Announce License of BioWa's COMPLEGENT(TM) Technology
16 Jul 2008 Merck: Erbitux Approved for Use in Metastatic Colorectal Cancer in Japan
16 Jul 2008 Symphogen and Biovitrum have Initiated a Novel Treatment Study in Autoimmune Bleeding Disorder (ITP) Patients
15 Jul 2008 Lonza and Kyowa Hakko extend their strategic collaboration
14 Jul 2008 Amgen Announces Positive Top-Line Results for Denosumab Treatment of Bone Loss in Men With Non-Metastatic Prostate Cancer Undergoing Androgen Deprivation Therapy
14 Jul 2008 Nycomed adds veltuzumab for autoimmune diseases to R&D pipeline
14 Jul 2008 MRC Technology and Biolex Therapeutics Successfully Complete Collaboration to Humanize a Novel Antibody Targeting CD20
10 Jul 2008 Recruitment Completed in Ofatumumab CLL Front Line Study
09 Jul 2008 Boehringer Ingelheim Gains Access to Additional MorphoSys Technology
09 Jul 2008 Merck Begins Erbitux Phase III Clinical Study in Gastric Cancer
09 Jul 2008 Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (basiliximab) for Noninfectious Uveitis
08 Jul 2008 Seattle Genetics Announces Antibody-Drug Conjugate Collaboration with Daiichi Sankyo
07 Jul 2008 ImmunoGen, Inc. Announces Start of IMGN388 Clinical Testing
07 Jul 2008 Phase 2 Study Of IMC-A12 for Advanced Soft Tissue Sarcoma Opens for Patient Enrollment
03 Jul 2008 Phase III ARISER study with RENCAREX(R): patient recruitment successfully completed
02 Jul 2008 Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
01 Jul 2008 UCB's Cimzia(R) filed with EMEA for treatment of rheumatoid arthritis
30 Jun 2008 Takeda Submitted a New Drug Application for Anti-Cancer Agent, panitumumab (recombinant)
29 Jun 2008 New Data Show Preemptive Treatment May Significantly Reduce Skin Toxicities in Patients Receiving Vectibix(R) (Panitumumab)
29 Jun 2008 Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
25 Jun 2008 IMC-A12 Plus Temsirolimus Clinical Trial for Advanced Cancer Opens for Patient Enrollment
25 Jun 2008 CuraGen Announces Initiation of Phase II Trial of CR011-vcMMAE in Patients with Advanced Breast Cancer
25 Jun 2008 Genmab Initiates Study of Zalutumumab with Radiotherapy in Head and Neck Cancer
24 Jun 2008 Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases
19 Jun 2008 Amgen and Wyeth Statement on Outcome of Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) Meeting

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up